News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
706,192 Results
Type
Article (40435)
Company Profile (257)
Press Release (665499)
Multimedia
Podcasts (59)
Webinars (14)
Section
Business (204574)
Career Advice (2015)
Deals (35485)
Drug Delivery (95)
Drug Development (81268)
Employer Resources (172)
FDA (16260)
Job Trends (14913)
News (345973)
Policy (32649)
Tag
Academia (2562)
Accelerated approval (9)
Adcomms (23)
Allergies (96)
Alliances (49665)
ALS (109)
Alzheimer's disease (1443)
Antibody-drug conjugate (ADC) (155)
Approvals (16254)
Artificial intelligence (310)
Autoimmune disease (28)
Automation (18)
Bankruptcy (361)
Best Places to Work (11649)
BIOSECURE Act (19)
Biosimilars (121)
Biotechnology (182)
Bladder cancer (93)
Brain cancer (33)
Breast cancer (365)
Cancer (2867)
Cardiovascular disease (212)
Career advice (1684)
Career pathing (30)
CAR-T (186)
CDC (30)
Cell therapy (499)
Cervical cancer (22)
Clinical research (66934)
Collaboration (1016)
Company closure (3)
Compensation (686)
Complete response letters (22)
COVID-19 (2634)
CRISPR (56)
C-suite (326)
Cystic fibrosis (112)
Data (2992)
Decentralized trials (2)
Denatured (20)
Depression (60)
Diabetes (346)
Diagnostics (6429)
Digital health (23)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (137)
Drug pricing (121)
Drug shortages (28)
Duchenne muscular dystrophy (124)
Earnings (87474)
Editorial (40)
Employer branding (21)
Employer resources (148)
Events (113967)
Executive appointments (845)
FDA (17905)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (933)
Gene editing (129)
Generative AI (22)
Gene therapy (376)
GLP-1 (780)
Government (4509)
Grass and pollen (4)
Guidances (181)
Healthcare (18886)
HIV (40)
Huntington's disease (30)
IgA nephropathy (39)
Immunology and inflammation (148)
Immuno-oncology (8)
Indications (39)
Infectious disease (2806)
Inflammatory bowel disease (149)
Inflation Reduction Act (10)
Influenza (62)
Intellectual property (119)
Interviews (313)
IPO (16602)
IRA (44)
Job creations (3652)
Job search strategy (1426)
Kidney cancer (13)
Labor market (52)
Layoffs (493)
Leadership (19)
Legal (7935)
Liver cancer (79)
Longevity (11)
Lung cancer (399)
Lymphoma (209)
Machine learning (11)
Management (58)
Manufacturing (384)
MASH (90)
Medical device (13468)
Medtech (13473)
Mergers & acquisitions (19600)
Metabolic disorders (847)
Multiple sclerosis (97)
NASH (16)
Neurodegenerative disease (114)
Neuropsychiatric disorders (32)
Neuroscience (2119)
NextGen: Class of 2025 (6534)
Non-profit (4501)
Now hiring (47)
Obesity (427)
Opinion (217)
Ovarian cancer (102)
Pain (106)
Pancreatic cancer (120)
Parkinson's disease (186)
Partnered (22)
Patents (296)
Patient recruitment (164)
Peanut (51)
People (57814)
Pharmaceutical (63)
Pharmacy benefit managers (21)
Phase I (20866)
Phase II (29484)
Phase III (21936)
Pipeline (1628)
Policy (200)
Postmarket research (2566)
Preclinical (8896)
Press Release (64)
Prostate cancer (140)
Psychedelics (36)
Radiopharmaceuticals (253)
Rare diseases (460)
Real estate (5936)
Recruiting (66)
Regulatory (22660)
Reports (50)
Research institute (2328)
Resumes & cover letters (351)
Rett syndrome (9)
RNA editing (8)
RSV (49)
Schizophrenia (86)
Series A (158)
Series B (109)
Service/supplier (11)
Sickle cell disease (60)
Special edition (18)
Spinal muscular atrophy (148)
Sponsored (32)
Startups (3602)
State (2)
Stomach cancer (14)
Supply chain (76)
Tariffs (57)
The Weekly (37)
Vaccines (779)
Venture capital (54)
Weight loss (256)
Women's health (47)
Worklife (16)
Date
Today (69)
Last 7 days (359)
Last 30 days (1885)
Last 365 days (31259)
2025 (16774)
2024 (35256)
2023 (40109)
2022 (51243)
2021 (55777)
2020 (54144)
2019 (46602)
2018 (35083)
2017 (32159)
2016 (31542)
2015 (37611)
2014 (31392)
2013 (26425)
2012 (28654)
2011 (29338)
2010 (27406)
Location
Africa (724)
Alabama (61)
Alaska (7)
Arizona (243)
Arkansas (13)
Asia (38300)
Australia (6258)
California (7439)
Canada (2362)
China (670)
Colorado (321)
Connecticut (318)
Delaware (193)
Europe (82275)
Florida (1116)
Georgia (247)
Hawaii (1)
Idaho (59)
Illinois (640)
India (26)
Indiana (361)
Iowa (16)
Japan (227)
Kansas (108)
Kentucky (29)
Louisiana (14)
Maine (64)
Maryland (1026)
Massachusetts (5526)
Michigan (246)
Minnesota (451)
Mississippi (3)
Missouri (90)
Montana (28)
Nebraska (25)
Nevada (80)
New Hampshire (66)
New Jersey (2071)
New Mexico (28)
New York (2082)
North Carolina (1082)
North Dakota (8)
Northern California (3275)
Ohio (235)
Oklahoma (16)
Oregon (34)
Pennsylvania (1624)
Puerto Rico (17)
Rhode Island (36)
South America (1100)
South Carolina (34)
South Dakota (1)
Southern California (2779)
Tennessee (126)
Texas (1125)
United States (27576)
Utah (219)
Virginia (184)
Washington D.C. (72)
Washington State (633)
West Virginia (4)
Wisconsin (66)
706,192 Results for "northwest biotherapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Northwest Biotherapeutics Announces Upcoming Presentation On Next Generation Dendritic Cells for Enhanced Anti-Tumor Treatments
June 12, 2025
·
3 min read
Business
Northwest Biotherapeutics Announces Exclusive In-License of Portfolio of Dendritic Cell Technology and Intellectual Property
Northwest Biotherapeutics announced today that on June 12, 2024 it entered into an exclusive license from Roswell Park Comprehensive Cancer Center for a portfolio of dendritic cell technologies and intellectual property (IP).
June 17, 2024
·
6 min read
Business
Northwest Biotherapeutics Appoints Seasoned Business Executive and Investor To Its Board of Directors
Northwest Biotherapeutics announced today that it has appointed Mr. Pat Sarma to its Board of Directors effective March 18, 2024.
March 21, 2024
·
5 min read
Press Releases
Northwest Biotherapeutics Announces $5 Million Convertible Note Financing and Standby Facility for Up to $50 Million Additional Financing
December 27, 2024
·
4 min read
Press Releases
Calidi Biotherapeutics Inc. (NYSE American: CLDI) Developing Precision Genetic Medicine Platform for Cancer Treatment
July 9, 2025
·
3 min read
Press Releases
Cocrystal Pharma to Present at Life Science Innovation Northwest 2025 Conference
April 16, 2025
·
1 min read
BioCapital
Northwest Biotherapeutics Provides Update On Final Preparations For Marketing Authorization Application
Northwest Biotherapeutics provided an update today about the final preparations for the Marketing Authorization Application (MAA) that will be submitted to the Medicines and Healthcare Products Regulatory Agency (MHRA)(the equivalent of the U.S. FDA) in the U.K. for commercial approval of the Company’s DCVax®-L treatment for glioblastoma.
November 22, 2023
·
3 min read
Business
Northwest Biotherapeutics Moves From Optimization of Flaskworks Prototype to Fabrication of GMP-Compliant Units For Installation, Validation and Final Testing Prior to Regulatory Certification
Northwest Biotherapeutics announced today that the key development work for the Flaskworks manufacturing system has been completed and an external vendor has been engaged to produce GMP-grade units of the system.
February 6, 2024
·
9 min read
BioCapital
Northwest Biotherapeutics Announces That A Marketing Authorization Application Has Been Submitted To The UK MHRA For DCVax®-L For Glioblastoma
Northwest Biotherapeutics (OTCQB: NWBO) (“NW Bio”) announced today that a Marketing Authorization Application (MAA) was submitted yesterday to the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK for DCVax®-L for glioblastoma brain cancer.
December 21, 2023
·
7 min read
BioCapital
Northwest Biotherapeutics Announces That Dr. Linda Liau Has Joined The Company’s Scientific Advisory Board
Northwest Biotherapeutics announces that Dr. Linda Liau, MD, PhD, MBA has joined the Company’s Scientific Advisory Board.
September 12, 2023
·
3 min read
1 of 70,620
Next
